Page 158 - ITU KALEIDOSCOPE, ATLANTA 2019
P. 158

2019 ITU Kaleidoscope Academic Conference




                                                                         4.  KEY TRENDS IN AI ERA

                                                              Following the development track, AI is seen as one of the
                                                              most prominent  technologies in the intelligent  stage, as is
                                                              also reflected by the national strategy documents of countries.
                                                              The following sections will extract the interaction of AI on
                                                              digital  health  separately  from  the  intelligence  stage  and
                                                              discuss  the  key  trends  from  the  perspective  of  the  main
                                                              component factors of AI. They are data, computing power
                                                              and algorithms which can correspond to the data, platform
                                                              and application of the ICT part in the previous framework.

                                                              4.1    Comprehensive description of health data
            Figure 4 – Interaction between ICT and health at Stage 2
                                                              Large  amounts  of  data  are  the  foundation  of  intelligent
           3.3    Service intelligentization                  services. In order to more fully describe the state of human
                                                              health,  two  dimensions  of  expansion  are  undertaken,
                                                              horizontally and vertically.
           The third stage is service intelligentization. In the previous
           stage,  the  digitization  of  health  records  laid  a  good
           foundation of data sharing and intelligent services for a wider   Horizontal  expansion  refers  to  the  full  coverage  of  a  life
                                                              cycle.  With  the  keen  perception  of  sensors  and  strong
           range  [23].  Figure  5  shows  the  interaction  in  blue.  Data,
           computing platforms and personalized applications are the   analytical  ability  of  AI,  it  could  ideally  cover  the  whole
                                                              process  of  user  life,  continuously  monitoring  and
           main factors to promote service intelligentization. Data is not
           limited  to  the  digitization  of  records,  but  also  refers  to   comprehensively  analyzing  various  data  indicators,
                                                              including physiological data (such as blood pressure, pulse),
           emerging big data technology, such as IBM Watson built on
           big data analysis. Computing platforms are to support the   environmental data (such as air that is breathed in), behavior
                                                              data  (such  as  exercising  or  diet),  etc.  IBM  Watson  and
           process  of  ‘massive’  EHR  and  mining  the  hidden  values.
           With  the  increasing  volume  and  complexity  of  patient   Microsoft  Azure  have  built  a  population  health  platform
                                                              based  on  “AI+Cloud”,  providing  an  overview  analysis  of
           information,  the  expectations  for  rapid  and  accurate
           diagnosis and treatment also rises. AI/ML has great potential   various  impact  factors  on  personal  health.  Potential
                                                              stakeholders  including  wearables  companies,  medical
           to  assist  physicians  with  reference  diagnosis  and
           personalized  treatment.  An  evidence-based  medical   institutions, HIS developers and health insurance, etc. can all
                                                              benefit from this model. From “treat diseases” to “prevent
           decision-making system was established with the help of a
           large number of cancer clinical knowledge, molecular and   diseases”, it will to some extent alleviate the gap between
                                                              supply and demand, mentioned in section 1.
           genomic  data  and  cancer  case  history  information  [24].
           DeepMind  also  stepped  into  the  AI  for  health  field  and
           announced  its  first  major  health  project  in  2016:  a   Vertical  expansion  refers  to  the  deep  description  of  life.
           collaboration with the Royal Free London NHS Foundation   Measurement technology is continuously evolving, from the
           Trust, to assist in the management of acute kidney injury [25].   individual level, anatomical level, human tissue, metabolism,
           Not only diagnosis and treatment are penetrated, intelligent   to protein, genetic aspects. Precision medicine was proposed
           applications can be integrated in every part of the service   with  the  rapid  advancement  of  genome  sequencing
           chain, and the corresponding application comes into being,   technology and the cross-application of big data technology.
           which will be illustrated in section 4.3.          The  United  States  initially  invested  $215  million  in  the
                                                              Precision  Medicine  Initiative,  China  has  planned  to  invest
                                                              US$9 billion and mentioned precision medicine in the “13th
                                                              Five-Year  Plan”;  Australia  launched  the  Zero  Childhood
                                                              Cancer Program in 2016 with an investment of A$20 million;
                                                              the  French  genome  medical  treatment  2025  was  also
                                                              launched with an investment of 670 million euros.  As the
                                                              granularity of health data descriptions deepens, AI is able to
                                                              establish  an  interpretation  bridge  between  genetic
                                                              information  and  clinical  characterization,  and  ultimately
                                                              achieve personalized and precise treatment.

                                                              4.2    Customized computing abilities for scenarios

                                                              With rapid increases in the amount and complexity of health
                                                              data, higher requirements are proposed for the platform. Two
            Figure 5 – Interaction between ICT and health at Stage 3   ways for improvement are: processors and architecture.





                                                          – 138 –
   153   154   155   156   157   158   159   160   161   162   163